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Background 
Half RIWKHZRUOG¶VSRSXODWLRQsuffers from untreated oral conditions, affecting a total 
of 3.5 billion people in 2015; 2.5 billion people were affected by untreated caries in 
permanent teeth, 573 million children by untreated caries in deciduous teeth, 538 
million people by severe periodontal disease, and 276 million people were affected 
by total tooth loss.1 Dental diseases produce large societal costs, both in terms of 
treatment costs and losses to productivity; for the EU-28 countries, dental diseases 
led to treatment costs of $100 billion (92 billion EUR) and productivity losses of $57 
billion (52 billion EUR) in 2015.2,3 
 
Given this, generating and implementing evidence-based policy is an important aim 
for many public-funded health systems.4 In dentistry, this is based on the assumption 
that evidence-based healthcare increases the efficiency and effectiveness of 
interventions to improve oral health at a population level.5 However, it is increasingly 
recognised that a OLQHDURUµORJLFPRGHO¶WKDWOLQNVthe generation of research 
evidence with its use, is overly simplistic.6 This paper challenges an uncritical 
interpretation of the evidence-based paradigm and explores approaches to the 
evaluation of complex interventions and how they can be embedded into policy and 
practice to improve oral health at a population level. 
 
The challenge of generating the evidence 
The process of generating robust research evidence has traditionally relied on 
randomised controlled clinical trials (RCTs) to empirically evaluate interventions.7 
Any observed effect is pooled statistically and the evidence is then synthesised to 
create evidence-based policies.8 Research evidence is then HLWKHUµSXVKHG¶IURPWKH
research community (in JXLGHOLQHVRUHYLGHQFHVXPPDULHVRUµSXOOHG¶E\FOLQLFLDQV
who are seeking evidence-based approaches to inform their approach to care. 
However, there are a number of inherent difficulties with a push-pull assumption 
when the intervention is complex,9 or where it aWWHPSWVWR³introduce new, or modify 
existing, patterns of collective action in health care or some other formal 
RUJDQLVDWLRQDOVHWWLQJ´10  
 
The first problem is that the quality of many trials remains poor. In Glasziou et al¶V
study, 40-89% of the interventions were not replicable due to a poor description and 
in most studies, at least one Primary Outcome Measure was changed, introduced or 
omitted.11 In Yordanov et al¶Vmethodological review and simulation study of trials 
included in Cochrane reviews, 43% of the 1,286 studies identified had at least one 
domain at high risk of bias and 142 of a random sample of 200 of the aforementioned 
trials were confirmed as high risk.12 Secondly, ³WULDOLVWV´ routinely pretend that 
XQFHUWDLQW\GRHVQ¶WH[LVW:HSLFNVLQJOHSRLQWHVWLPDWHVIRUDOORIWKHVHSDUDPHWHUV
create a design that would work well if all of those guesses happen to be true 
simultaneously (a very unlikely event) and then we put that design into a grant that 
we hope gets funded´.13 $VIXUWKHUKLJKOLJKWHGE\/HZLV³WKLVDSSURDFKOHDGVWRDQ
LQFUHDVHGULVNRIIDOVHO\QHJDWLYHRULQFRQFOXVLYHUHVXOWV´.  
 
An even more fundamental issue is that effect sizes alone are not enough to facilitate 
the implementation of research findings in clinical practice or public health³effect 
sizes do not provide policy makers with information on how an intervention might be 
UHSOLFDWHGLQWKHLUVSHFLILFFRQWH[WRUZKHWKHUWULDORXWFRPHVZLOOEHUHSURGXFHG´14 As 
Grant et al. highlight, one of the reasons why so much clinical research is ignored is 
because ³WKHUHLVQRWHQRXJKFRQWH[WXDOLQIRUPDWLRQSURYLGHGWRWUDQVIHUWKHUHVXOWV
IURPWKHWULDOVHWWLQJLQWRRWKHUVHWWLQJV´15 A further problem is the common conflation 
of efficacy and effectiveness; demonstrating that a health technology µZRUNV¶ 
(efficacy) does not necessarily mean that it can improve health at a population level 
(effectiveness).16  
 
Another critique of the evidence-based paradigm relates to how evidence is 
synthesised and analysed. Trials with positive results are published in approximately 
four to five years, whilst trials with null or negative results take six to eight years to 
publish.17 As multiple trials are required for one systematic review, they become 
highly resource intensive.18 This contrasts with the often rapidly moving policy 
context where structures at a micro, meso and macro level (i.e. at the level of the 
clinician, the commissioner of services and at a Government level respectively) can 
change very quickly. As Gannan et alKLJKOLJKW³emerging issues require access to 
high-TXDOLW\HYLGHQFHLQDWLPHO\PDQQHUWRLQIRUPV\VWHPDQGSROLF\UHVSRQVH´19  
 
Another concern with the process is that many systematic review methodologies 
have a tendency to strip out the policy context. This has led some researchers to 
adopt a theoretical approach to help guide the process of the review and make sure 
key elements are retained, particularly where the intervention is complex. 
Implementation frameworks, such as the Knowledge-To-Action framework,20 and 
other methods (for example realist syntheses) explicitly seek to include and 
understand the role of context and how and why interventions or programmes work.21 
We consider this to be critical. $V1RUWKULGJH	0HWFDOIKLJKOLJKWWKHUHLVD³QHHGWR
extract the core issues from the context in which they are embedded in order to 
EHWWHUHQVXUHWKDWWKH\DUHWUDQVIHUDEOHDFURVVVHWWLQJV´22 Such insights highlight the 
value of shifting from the traditionally used binary question of effectiveness towards a 
more sophisticated explanation.23  
 
Once evidence has been synthesised, the response by the evidence user can be 
idiosyncratic and these problems become magnified when interventions are 
introduced into complex social or organisational systems.24 A number of system-
related challenges relate to this process and introduce variation that needs to be 
considered and managed. Such challenges refer to the variability and stability (and 
predictability) across and within organisations, the range of solutions applicable to 
any given problem, the multiple mechanisms involved, the differing ability of the 
individual/organisation to affect these mechanisms and the varying relationships 
between mechanisms and outcomes (in terms of linearity and impact).25 Equally, 
evidence LVRIWHQ³ZHLJKHG-XS´DORQJVLGHRWKHUFOLQLFDOIDFWRUVDQGH[SHULHQWLDO
knowledge can be privileged.26,27 As a result, the production of evidence in its own 
right is not sufficient per se to influence change.28 Decision-making is a process, not 
a one-off event, and relies on productive on-going relationships and the 
organisational context.29,30 
 
Producing change in population oral health? 
One of the key challenges relates to the relevance of the RCTs and the degree of 
their use to shape policy DLPLQJWRLPSURYHWKHSRSXODWLRQ¶VRUDOKHDOWK. There is 
evidence that outputs from trials have had a direct impact on public health policy. 
Recently, Chestnutt et al¶Vµ6HDORU9DUQLVK¶WULDOOHGWRDQHDULPPHGLDWHFHVVDWLRQRI
a national sealant scheme across Wales in favour of a fluoride varnish scheme. They 
concluded WKDW³Ln a community oral health programme utilising mobile dental clinics 
and targeted at children with high caries risk, the twice-yearly application of fluoride 
varnish resulted in caries prevention that is not significantly different from that 
obtained by applying and maintaining fissure sealants after 36 months´DQGWKDW
fluoride varnish was more cost-effective.31 Equally, Milsom et al.¶VWULDORQGHQWDO
screening programmes for school-aged children produced a policy change by the 
National Screening Committee in the United Kingdom (UK) and Innes et al¶VWULDORQ
the Hall technique made a substantive impact on the management of child caries.32,33 
However, this is in contrast with a number of trials whose results have had less 
impact to date.34,35  
 
As highlighted above, the use of the evidence-based paradigm can be applied 
without critical thought. At a population level, there are arguments for the inclusion of 
other study designs to augment the evaluation of dental public health programmes 
and health policies.36 The recent debate following the publication of the Cochrane 
review on the effectiveness of water fluoridation illustrates this point. This review was 
influenced by the exclusion of observational studies and concluded that ³WKHUHLVYHU\
little contemporary evidence, meeting the review's inclusion criteria´.37 However, in 
their critique, Rugg-Gunn et al. argued that ³Zith public health interventions >«@
there are frequently no such trials because the highly complex practical, ethical and 
financial factors involved mean that RCTs are not feasible´38 They go on to argue 
that unlike individual clinical interventions, evidence has to be drawn from a wide 
variety of research designs to determine whether a complex public health 
intervention is cost effective. This approach was undertaken by the National Health 
and Medical Research Centre (NHMRC) in Australia, who reached a different 
conclusion: ³the NHMRC strongly recommends community water fluoridation as a 
safe, effective and ethical way to help reduce tooth decay across the population´39  
 
Antibiotic prophylaxis for infective endocarditis is another example. This was 
common-place in the UK until 2008, when the National Institute of Clinical 
([FHOOHQFH¶V1,&(stated WKDW³DQWLELRWLFSURSK\OD[LVDJDLQVWLQIHFWLYHHQGRFDUGLWLV
is not recommended IRUSHRSOHXQGHUJRLQJGHQWDOSURFHGXUHV´40 NICE relies heavily 
on evidence from clinical trials and evidence from other study designs downgraded; 
as suchLWDSSHDUHGµORFNHGLQWR¶DUHFRPPHQGDWLRQWKDWZDVDWRGGVZLWKWKH
international consensus.41 It also became at odds with a large observational study 
that demonstrated that the cessation of antibiotic prophylaxis (NICE guidance) had 
increased the risk of patients contracting infective endocarditis.42 In recognition of 
this confusion and yet without any further evidence, NICE changed its 
UHFRPPHQGDWLRQLQWR³DQWLELRWLFSURSK\OD[LVDJDLQVWLQIHFWLYHHQGRFDUGLWLVLV
not recommended routinely for people undergoing dental proceGXUHV´, creating a 
great deal of confusion.43  
 
The use of taxation for Sugar-Sweetened Beverages (SSBs) is another area where 
the uncritical adoption of the evidence-based paradigm is problematic. Empirically 
evaluating WKHLPSDFWRIDµVXJDU-WD[¶ would require participants to be randomised to 
different price levels in any one country. This would be clearly unfeasible. 
Furthermore, making cross-country comparisons would be highly resource intensive 
and a systematic review using multiple trials would be even more unlikely.  
 
Quasi-experimental methodologies have been used to show reduction in the 
consumption of SSBs and increase in water consumption after implementing a sugar 
tax,44 while modelling studies have explored the potential impact of such an 
intervention on population health and the economy.45 In the absence of evidence 
from experimental evidence, a health care decision maker has to ask: which other 
types of information are suitable for timely and evidence-informed decision making? 
Health policies, particularly with regards to public health, often need to be formulated 
at a time point when the respective evidence base is still rather limited.46 And the 
traditional evidence-based model around RCTs does not fit well public health 
interventions that require strong theoretical underpinnings, wider methodological 
approaches and a focus on complex systems.47  
 
The application of theoretical approaches to help evidence use 
Psychological theory is increasingly being used to predict individual behaviour 
change and improve the adoption of evidence.48 These theories set out to 
understand the proximal determinants of behaviour including beliefs (cognitions), 
knowledge, and the attiWXGHVDQGPRWLYDWLRQVWKDWXQGHUOLHDQLQGLYLGXDO¶V
behavioural intentions, and ultimately their behaviour.49,50 The underlying assumption 
is that understanding behaviour is enough to produce changes at scale.51 Such 
approaches have been used in dentistry in relation to adherence to guidelines for 
fissure sealants,52 intra-oral radiographs,53 caries management for children,54 and 
advising on oral health-related behaviours.55 
 
To date, psychological theories have been shown to be important as they target 
behavioural drivers that are potentially amenable to change.56 Recent developments 
have also seen an attempt to synthesise these. The Theoretical Domains Framework 
(TDF) brings together a large number of psychological theories and constructs that 
have been found to influence health SURIHVVLRQDO¶VEHKDYLRXU. 57,58 The 14 domains of 
the TDF include constructs such as, knowledge, skills, social/professional role and 
identity, and beliefs about capability.59    
 
The TDF has also been applied to dentistry: antibiotic prescribing,60 caries 
management,61,62 and the application of fluoride varnish to childUHQ¶VWHHWK.63 
However, there remains a lack of focus on the organisational context, including 
practice culture and other factors that can influence individual clinician¶s decision 
making. This is problematic because the implementation of evidence requires 
complex changes in clinical practice within complex health systems. These take 
place not EHFDXVHRILQGLYLGXDO¶VEHKDYLRXUDOSURFHVVHVEXWWKURXJKFROOHFWLYHDFWLRQ
enacted by teams within health care organisations.64 For example, dentists do not 
adopt evidence-based preventive care because of a lack of inertia, up-to-date 
knowledge or skills, but commonly because of practical (existing logistics of the 
GHQWDOSUDFWLFHFXOWXUDOGHQWLVWVSHUFHSWLRQVRIWKHLUSDWLHQWVDQGSDWLHQWV¶
motivations, values, co-operativeness) and economic (time constraints, financial risk, 
funding systems) barriers.65,66 Arguably, rather than targeting different levels for 
effective change ± individual clinician (e.g. dentist, dental hygienist), health care unit 
or team (e.g. dental practice), health care organisation (e.g. National Health Service) 
± the system µas a whole¶ needs to be considered.67   
 
What can implementation science offer? 
Given the persistent and often intractable challenges of evidence-based healthcare, 
there has been a growing interest in the study of implementation processes and 
approaches in order to unpack the µEODFNER[¶Implementation research reinforces 
the assertion that evidence production does not naturally flow into evidence use. As 
highlighted above, people use tacit and collective knowledge to determine whether 
evidence is credible, and whether it fits with their experience and practice.27 
Evidence users are not passive recipients and their practice is influenced by the 
context in which they work. Organisation features such as organisational slack, 
resources, the nature and quality of leadership, culture, and communication systems 
are all important.68  
 
The evidence base suggests that there is more promise in approaches that are 
theoretically based, interactive and tailored.69 For example, there is growing support 
for the use of change agents in implementation processes. One such change agent 
is facilitation, where evidence is three times more likely to be adopted.70,71 Training 
lay workers as facilitators of quality improvement in Vietnam showed a significantly 
positive effect on neonatal mortality.72 Implementation frameworks are also important 
in the choice and development of interventions, for identifying appropriate outcomes, 
measures and variables of interest, and in guiding the evaluation of implementation 
processes and outcomes. These include the Promoting Action on Implementation in 
Health Services (PARIHS), Knowledge to Action, the Consolidated Framework for 
Implementation Research, and Normalisation Process Theory. These help to shift the 
thinking away from viewing the gap between evidence and practice as being a 
µservice problem¶, to one that acknowledges the importance of how knowledge is 
created. The idea that users and producers of evidence occupy two separate worlds 
has not been helpful in accelerating progress with the evidence-based practice 
agenda. As such there is increasing interest in the development of more collaborative 
type arrangements such as Collaborations for Leadership in Applied Health and Care 
in the UK. Here, the producers and users of evidence work together to create 
knowledge that solve service challenges in more co-productive ways. 
 
Discussion 
This paper has argued that an uncritical adherence to the evidence-based paradigm 
is not always feasible, desirable, or ethical for complex healthcare interventions.73 In 
addition, it has argued that evidence production is not enough to stimulate evidence 
use particularly highlighting the importance of carefully considering the theoretical 
underpinnings of change and the role of the context for implementation.  
 
There are a number of pragmatic steps that could be taken when designing trials of 
complex interventions to approve adoption. These include thinking about 
implementation a priori and working with policy-makers, commissioners, public health 
officials, clinicians and the public at the beginning of the evidence generation process 
to ensure that the research agenda is co-produced. Factors associated with the 
context of a complex intervention should also be considered at the earliest stage in 
the evaluation process, using theoretically informed feasibility and pilot studies.74 
Theoretical frameworks should be used more prospectively as part of the trial design 
process for complex interventions (or other ex-post methodologies).75,76 Equally, 
process evaluations should be run in parallel alongside empirical evaluations of 
complex interventions LQRUGHUWRKHOSXQGHUVWDQGµWKHFDXVDODVVXPSWLRQV
underpinning the intervention and « KRZLQWHUYHQWLRQVZRUNLQSUDFWLFH¶77 In addition, 
the use of Studies Within A Trial can help understand the best way to ensure 
adequate representation of those that are recruited.78 
 
The standardisation of outcome measures used in trials of amenable population 
programmes to promote oral health would also be of real value. As highlighted by 
Kirkham, there is ³JURZLQJUHFRJQLWLRQWKDWLQVXIILFLHQWDWWHQWLRQKDVEHHQSDLGWRWKH
outcomes measured in clinical trials, which need to be relevant to health service 
users and other people making choices about health care if the findings of research 
DUHWRLQIOXHQFHSUDFWLFH´.79 In the past, the heterogeneity of outcome measures used 
by many trialists has made meta-analysis difficult and has added to research waste. 
By taking a co-produced approach to developing a Core Outcome Set (COS), this 
type of research waste can be reduced.91 This heterogeneity of outcomes 
measurement has also been a feature of oral health research and work to validate 
COSs (e.g. the current project between the World Dental Federation and the 
International Consortium for Health Outcomes Measurement) may inform the 
consistent selection of oral health outcomes for relevant interventions. 
 
More thought should be given to the type of evidence that is assimilated in 
systematic reviews of large scale programmes to improve oral health, including the 
use of ex-post and ex-ante designs. Ex-post techniques typically evaluate the impact 
of an already implemented health policy programme and include a range of quasi-
experimental methods including Instrumental Variables, Difference-in-Difference, 
panel data analyses using fixed or random effects, and Regression-Discontinuity-
Designs (see Listl et al.).80 A recent study used such an approach to evaluate the 
impact of a SSB tax in Mexico. The study showed a significant reduction in 
consumption, since its introduction in 2014.81 In contrast, ex-ante techniques are 
designed to simulate the future response resulting from hypothetical interventions 
and to make comparisons with simulated alternative scenarios of interest to the 
decision maker.72 Ex-ante methods include structural modelling, agent-based 
modelling and micro-simulation and unlike the ex-post methods can help predict the 
short, mid and long-term health effects of an intervention.82,83 Such methodologies 
can provide very helpful information on the evaluation of policies and interventions 
that would otherwise not be rigorously evaluated as the standard RCT related 
methodologies are neither feasible nor suitable.  
 
More attention should be paid to an understanding of context and attempts should be 
made not to throw away evidence during the assimilation process that could help 
describe this. Again, the use of theoretical frameworks and logic models to help 
guide the review process are key.84 Such approaches can ³aid in the 
conceptualization of the review focus and illustrate hypothesized causal links, identify 
effect mediators or moderators, specify intermediate outcomes and potential harms, 
and justify a priori subgroup analyses when differential effects are anticipated´. They 
can describe the system into which the intervention and context takes place (system-
based logic model) or the processes and causal pathways that lead to the outcomes 
(process-orientated logic model).85 They can also help identify the most relevant 
inclusion criteria and clarify the interpretation of results for policyǦrelevant 
conclusions. 
 
Finally, more thought should be given to the use of realist reviews and rapid realist 
reviews in the dental literature, which specifically account for context and try to 
XQGHUVWDQGWKHXQGHUO\LQJSURJUDPPHWKHRULHVµZKDWZRUNVIRUZKRPZK\DQGLQ
what circumsWDQFHV¶. These would help to provide a more nuanced understanding, 
augment and broaden a triangulation process with existing evidence-based 
approaches for large-scale change in population oral health.86 Moving towards the 
aforementioned suggestions presents a major but welcome challenge for oral health 
research as it would enrich the evaluation methodological scope and facilitate the 
wider use and implementation of appropriate evidence into clinical practice and 
public health, thereby having potential for improving the oral health of the population. 
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